Acebutolol

CAS No. 37517-30-9

Acebutolol ( Acebutolol; Acetobutolol; Neptal; Prent; Sectral; Dl-Acebutolol )

Catalog No. M14294 CAS No. 37517-30-9

A cardioselective beta blocker for the treatment of hypertension and arrhythmias.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Acebutolol
  • Note
    Research use only, not for human use.
  • Brief Description
    A cardioselective beta blocker for the treatment of hypertension and arrhythmias.
  • Description
    A cardioselective beta blocker for the treatment of hypertension and arrhythmias.Hypertension Approved
  • Synonyms
    Acebutolol; Acetobutolol; Neptal; Prent; Sectral; Dl-Acebutolol
  • Pathway
    Angiogenesis
  • Target
    Adrenergic Receptor
  • Recptor
    Adrenergic Receptor
  • Research Area
    Cardiovascular Disease
  • Indication
    Hypertension

Chemical Information

  • CAS Number
    37517-30-9
  • Formula Weight
    336.43
  • Molecular Formula
    C18H28N2O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CCCC(=O)NC1=CC(=C(C=C1)OCC(CNC(C)C)O)C(=O)C
  • Chemical Name
    N-[3-Acetyl-4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]phenyl]butanamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Milveterol hydrochlo...

    Milveterol (GSK 159797) is a potent, selective long-acting β2 adrenoceptor agonist with pEC50 of 10.2 in cell-based assays, displays good β2/β1 selectivity.

  • Yohimbine

    Yohimbine is an indole alkaloid that has high affinity for the α2-adrenergic receptors with Ki of 1 nM for α2A, α2B and α2C.

  • BRL 37344 sodium

    BRL 37344 is a potent and selective β3 adrenoceptor agonist with Ki of 287 nM; has weaker binding affinity for β1 and β2 receptors with Ki of 1750 and 1120 nM, respectively.